Corpus ID: 17346249

Mini-Review Premenstrual Syndrome and Premenstrual Dysphoric Disorder

  title={Mini-Review Premenstrual Syndrome and Premenstrual Dysphoric Disorder},
  author={Paula K. Braverman}
Premenstrual symptoms are experienced by up to 90% of women of child bearing age. A smaller subset meet criteria for premenstrual syndrome (PMS) and less than 10% are diagnosed as having premenstrual dysphoric disorder (PMDD). This review will describe the epidemiology, etiology, and treatment of PMS and PMDD. When literature specifically applicable to adolescents is available, that will be noted. However, most of the research and literature has focused on adult women and this review will… Expand

Tables from this paper

The main objective of this article is to review the potential treatment for premenstrual syndrome in unani medicine. Expand
Premenstrual Syndrome is described as a collection of predictable physical, cognitive, affective, and behavioral symptoms that occur cyclically during the luteal phase of the menstrual cycle andExpand
Social workers' knowledge of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): implications for assessment practices with mothers
Some women experience premenstrual syndrome (PMS), and its more severe presentation as premenstrual dysphoric disorder (PMDD), which seriously limits their coping ability in daily life, includingExpand
Premenstrual Syndrome, Associated Symptoms and Evidence – Based Nursing Management: A Comparative Study Between Rural Menoufia Governorate (Egypt) and Hodidha Governorate (Yemen)
Assessment of premenstrual symptoms, self care practices among women at reproductive age attending Maternal and Child Health centers in Menoufia governorate, Egypt and Hodidha governorates, Yemen and the effect of evidence-based nursing management on severity of pre menstrual syndrome found clients experience decrease severity after administration of evidence based nursing management. Expand
Dysphoric milk ejection reflex: A case report
The authors suggest that an abrupt drop in dopamine may occur when milk release is triggered, resulting in a real or relative brief dopamine deficit for affected women. Expand


Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners.
This review presents a comprehensive, practical description of what the clinician needs to know to diagnose and treat adverse premenstrual symptoms at all levels of severity. Expand
Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature.
  • T. Silber, Adela Valadez-Meltzer
  • Psychology, Medicine
  • The Journal of adolescent health : official publication of the Society for Adolescent Medicine
  • 2005
Case reports of successfully treated teenagers with PMDD may provide some justification for the compassionate use of fluoxetine for adolescent girls who are being disabled by PMDD, but more research is called for: a randomized placebo-controlled trial in adolescents is warranted. Expand
The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder - clinical procedures and research perspectives
  • U. Halbreich
  • Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2004
The current diagnostic entities are critically reviewed, problems with the current definitions are delineated and a unified definition is proposed, and the recommended clinical practical diagnostic process and differential diagnosis are described. Expand
Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
Beyond the conservative treatment options such as lifestyle and stress management, other nonantidepressant treatments, or the more extreme interventions that eliminate ovulation altogether, the serotonin reuptake inhibitors (SRIs) are emerging as the most effective treatment option for this population of women. Expand
Premenstrual disorders: epidemiology and disease burden.
  • D. Mishell
  • Medicine
  • The American journal of managed care
  • 2005
Diagnostic criteria established for premenstrual disorders may now enable physicians to evaluate their patients' complex symptoms more precisely and recommend a form of treatment that can alleviate the original complaint and improve healthcare for women. Expand
Treatment of premenstrual dysphoria with alprazolam. A controlled study.
Improved study design, which addressed methodologic flaws of most previous studies of treatment outcome of "premenstrual syndrome" may account, in part, for the ability to demonstrate significant drug/placebo differences. Expand
Recognizing and treating premenstrual dysphoric disorder in the obstetric, gynecologic, and primary care practices.
  • F. Ling
  • Medicine
  • The Journal of clinical psychiatry
  • 2000
The author discusses self-report instruments, which are valuable tools for diagnosis when combined with the ICD-10 criteria for premenstrual syndrome (PMS) or the DSM-IV criteria for PMDD and the ruling out of medical and psychiatric conditions that cause similar symptoms. Expand
Prevalence and correlates of the premenstrual syndrome in adolescence.
The results suggest that the experience of PMS in adolescence may be mediated by perceived health status; the roles of mental health and maternal influence in the development of adolescent PMS may be minimal. Expand
Premenstrual Syndrome in Adolescents and Body Composition
Premenstrual syndrome (PMS) consists of physical and/or psychological premenstrual symptoms that interfere with usual life performance and current treatment recommendations includes lifestyle change, exercise and various drugs or supplements that suppress the rise and fall of ovarian steroids or augment serotonin. Expand
Premenstrual syndrome and associated symptoms in adolescent girls.
PMS and dysmenorrhea are frequently overlapping and it is found that PMS is associated with dietary habits and which nutritional supplements affect the PMS-associated symptoms and signs. Expand